Literature DB >> 7706486

Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide.

R M Tuder1, B E Flook, N F Voelkel.   

Abstract

Endothelial cells constitute an essential integrator of factors that effect blood vessel remodeling induced by chronic hypoxia. We hypothesized that vascular endothelial growth factor (VEGF) may participate in the lung response to acute and to chronic hypoxia. We found that ex vivo perfusion of isolated lungs under hypoxic conditions (when compared with normoxia) caused an increase in lung tissue mRNA of VEGF and of the VEGF receptors KDR/Flk and Flt. Chronic hypobaric hypoxia also increased lung tissue mRNA levels of VEGF, KDR/Flk, and Flt and the amount of VEGF protein. In situ hybridization studies demonstrated increased VEGF and KDR/flk hybridization signals in lungs from chronically hypoxic rats. Since endotoxin treatment of rats decreased lung VEGF mRNA, we postulated that nitric oxide (NO) or an NO-related metabolite might be involved in lung VEGF gene expression. Indeed, sodium nitroprusside, a NO donor, decreased and L-NAME (N-nitro-L-arginine methyl ester), an inhibitor of NO-synthesis, increased both VEGF and VEGF receptor transcripts. We conclude that VEGF in the isolated perfused lung acts as an early gene in response to hypoxia and that lung VEGF and VEGF receptor mRNA levels are influenced by hypoxia and NO-dependent mechanisms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7706486      PMCID: PMC295709          DOI: 10.1172/JCI117858

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

2.  Proliferation of lung cells in chronically hypoxic rats. An autoradiographic and radiochemical study.

Authors:  C Niedenzu; K Grasedyck; N F Voelkel; S Bittmann; J Lindner
Journal:  Int Arch Occup Environ Health       Date:  1981       Impact factor: 3.015

3.  Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells.

Authors:  N Ferrara; W J Henzel
Journal:  Biochem Biophys Res Commun       Date:  1989-06-15       Impact factor: 3.575

4.  Human vascular permeability factor. Isolation from U937 cells.

Authors:  D T Connolly; J V Olander; D Heuvelman; R Nelson; R Monsell; N Siegel; B L Haymore; R Leimgruber; J Feder
Journal:  J Biol Chem       Date:  1989-11-25       Impact factor: 5.157

5.  Coordinate reciprocal trends in glycolytic and mitochondrial transcript accumulations during the in vitro differentiation of human myoblasts.

Authors:  K A Webster; P Gunning; E Hardeman; D C Wallace; L Kedes
Journal:  J Cell Physiol       Date:  1990-03       Impact factor: 6.384

6.  A kinetic study of lung DNA-synthesis during simulated chronic high altitude hypoxia.

Authors:  N Völkel; U Wiegers; V Sill; J Trautmann
Journal:  Thorax       Date:  1977-10       Impact factor: 9.139

7.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.

Authors:  D R Senger; S J Galli; A M Dvorak; C A Perruzzi; V S Harvey; H F Dvorak
Journal:  Science       Date:  1983-02-25       Impact factor: 47.728

8.  Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features.

Authors:  M Rabinovitch; W Gamble; A S Nadas; O S Miettinen; L Reid
Journal:  Am J Physiol       Date:  1979-06

9.  Agarose infiltration improves morphology of cryostat sections of lung.

Authors:  A C Halbower; R J Mason; S H Abman; R M Tuder
Journal:  Lab Invest       Date:  1994-07       Impact factor: 5.662

10.  Suramin binds to platelet-derived growth factor and inhibits its biological activity.

Authors:  M Hosang
Journal:  J Cell Biochem       Date:  1985       Impact factor: 4.429

View more
  117 in total

Review 1.  Future prospects for anti-cytokine treatment.

Authors:  M Feldmann; J Miotla; E Paleolog; R Williams; A M Malfait; P Taylor; F M Brennan; R N Maini
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

2.  Expression of the oxygen-regulated protein ORP150 accelerates wound healing by modulating intracellular VEGF transport.

Authors:  K Ozawa; T Kondo; O Hori; Y Kitao; D M Stern; W Eisenmenger; S Ogawa; T Ohshima
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

3.  Hypoxia-induced pulmonary vascular remodeling: a model for what human disease?

Authors:  N F Voelkel; R M Tuder
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

4.  Lake Tahoe invitation meeting 2002.

Authors: 
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

5.  Alveolar-capillary adaptation to chronic hypoxia in the fatty lung.

Authors:  C Yilmaz; P Ravikumar; D Gyawali; R Iyer; R H Unger; C C W Hsia
Journal:  Acta Physiol (Oxf)       Date:  2014-11-25       Impact factor: 6.311

6.  Redox systems of the cell: possible links and implications.

Authors:  Kumuda C Das; Carl W White
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-16       Impact factor: 11.205

Review 7.  Imaging of angiogenesis.

Authors:  Albert J Sinusas
Journal:  J Nucl Cardiol       Date:  2004 Sep-Oct       Impact factor: 5.952

Review 8.  Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension.

Authors:  Marjorie Barrier; Jolyane Meloche; Maria Helena Jacob; Audrey Courboulin; Steeve Provencher; Sébastien Bonnet
Journal:  Cell Mol Life Sci       Date:  2012-03-25       Impact factor: 9.261

9.  Pulmonary hemodynamics modify the rat pulmonary artery response to injury. A neointimal model of pulmonary hypertension.

Authors:  K Okada; Y Tanaka; M Bernstein; W Zhang; G A Patterson; M D Botney
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

10.  VEGF localisation in diabetic retinopathy.

Authors:  M Boulton; D Foreman; G Williams; D McLeod
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.